| CCL21 |
CCL21, SCYA21, UNQ784/PRO1600: Small-inducible cytokine A21 precursor |
F2RL1 |
F2RL1, GPR11, PAR2: Proteinase-activated receptor 2 precursor |
0.557 |
Evidence |
|
| CCL21 |
CCL21, SCYA21, UNQ784/PRO1600: Small-inducible cytokine A21 precursor |
SSTR3 |
SSTR3: Somatostatin receptor type 3 |
0.557 |
Evidence |
|
| CCL21 |
CCL21, SCYA21, UNQ784/PRO1600: Small-inducible cytokine A21 precursor |
MC4R |
MC4R: Melanocortin receptor 4 |
0.557 |
Evidence |
|
| CCL21 |
CCL21, SCYA21, UNQ784/PRO1600: Small-inducible cytokine A21 precursor |
AGTR1 |
AGTR1, AGTR1A, AGTR1B, AT2R1, AT2R1B: Type-1 angiotensin II receptor |
0.557 |
Evidence |
|
| CCL21 |
CCL21, SCYA21, UNQ784/PRO1600: Small-inducible cytokine A21 precursor |
HTR2C |
HTR2C, HTR1C: 5-hydroxytryptamine receptor 2C |
0.557 |
Evidence |
|
| CCL21 |
CCL21, SCYA21, UNQ784/PRO1600: Small-inducible cytokine A21 precursor |
F2R |
F2R, CF2R, PAR1, TR: Proteinase-activated receptor 1 precursor |
0.557 |
Evidence |
|
| CCL21 |
CCL21, SCYA21, UNQ784/PRO1600: Small-inducible cytokine A21 precursor |
FPRL1 |
FPRL1, FPR2, FPRH1, LXA4R: FMLP-related receptor I |
0.557 |
Evidence |
|
| CCL21 |
CCL21, SCYA21, UNQ784/PRO1600: Small-inducible cytokine A21 precursor |
IL8RB |
IL8RB, CXCR2: High affinity interleukin-8 receptor B |
0.557 |
Evidence |
|
| CCL21 |
CCL21, SCYA21, UNQ784/PRO1600: Small-inducible cytokine A21 precursor |
C5AR1 |
C5AR1, C5AR, C5R1: C5a anaphylatoxin chemotactic receptor |
0.557 |
Evidence |
|
| CCL21 |
CCL21, SCYA21, UNQ784/PRO1600: Small-inducible cytokine A21 precursor |
DRD1 |
DRD1: D(1A) dopamine receptor |
0.557 |
Evidence |
|
| CCL21 |
CCL21, SCYA21, UNQ784/PRO1600: Small-inducible cytokine A21 precursor |
FPR1 |
FPR1: fMet-Leu-Phe receptor |
0.557 |
Evidence |
|
| CCL21 |
CCL21, SCYA21, UNQ784/PRO1600: Small-inducible cytokine A21 precursor |
CHRM2 |
CHRM2: Muscarinic acetylcholine receptor M2 |
0.557 |
Evidence |
|
| CCL21 |
CCL21, SCYA21, UNQ784/PRO1600: Small-inducible cytokine A21 precursor |
RHO |
RHO, OPN2: Rhodopsin |
0.557 |
Evidence |
|
| CCL21 |
CCL21, SCYA21, UNQ784/PRO1600: Small-inducible cytokine A21 precursor |
ADRB2 |
ADRB2, ADRB2R, B2AR: Beta-2 adrenergic receptor |
0.557 |
Evidence |
|
| F2RL2 |
F2RL2, PAR3: Proteinase-activated receptor 3 precursor |
CXCL12 |
Stromal cell-derived factor 1 delta |
0.557 |
Evidence |
|
| F2RL2 |
F2RL2, PAR3: Proteinase-activated receptor 3 precursor |
XCL1 |
XCL1, LTN, SCYC1: Lymphotactin precursor |
0.557 |
Evidence |
|
| F2RL2 |
F2RL2, PAR3: Proteinase-activated receptor 3 precursor |
CCL5 |
CCL5, D17S136E, SCYA5: Small-inducible cytokine A5 precursor |
0.557 |
Evidence |
|
| F2RL2 |
F2RL2, PAR3: Proteinase-activated receptor 3 precursor |
CCL4 |
CCL4, CCL4L, LAG1, MIP1B, SCYA4, SCYA4L: Small-inducible cytokine A4 precursor |
0.557 |
Evidence |
|
| F2RL2 |
F2RL2, PAR3: Proteinase-activated receptor 3 precursor |
PF4 |
PF4, CXCL4, SCYB4: Platelet factor 4 precursor |
0.557 |
Evidence |
|
| F2RL2 |
F2RL2, PAR3: Proteinase-activated receptor 3 precursor |
CCL22 |
CCL22, A-152E5.1, MDC, SCYA22: Small-inducible cytokine A22 precursor |
0.557 |
Evidence |
|
| TLR4 |
TLR4: Toll-like receptor 4 precursor |
IL1A |
IL1A, IL1F1: Interleukin-1 alpha precursor |
0.557 |
Evidence |
|
| ARVCF |
ARVCF: Armadillo repeat protein deleted in velo-cardio-facial syndrome |
DSC2 |
DSC2, DSC3: Desmocollin-2 precursor |
0.557 |
Evidence |
|
| ARVCF |
ARVCF: Armadillo repeat protein deleted in velo-cardio-facial syndrome |
CDH13 |
CDH13, CDHH: Cadherin-13 precursor |
0.557 |
Evidence |
|
| ARVCF |
ARVCF: Armadillo repeat protein deleted in velo-cardio-facial syndrome |
DSG3 |
DSG3: Desmoglein-3 precursor |
0.557 |
Evidence |
|
| CCL24 |
CCL24, MPIF2, SCYA24: Small-inducible cytokine A24 precursor |
CCR5 |
CCR5: CCR5 receptor (Fragment) |
0.557 |
Evidence |
|